Suzanne Shusterman

3.0k total citations
63 papers, 1.7k citations indexed

About

Suzanne Shusterman is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Suzanne Shusterman has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 23 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Suzanne Shusterman's work include Neuroblastoma Research and Treatments (47 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Cancer therapeutics and mechanisms (12 papers). Suzanne Shusterman is often cited by papers focused on Neuroblastoma Research and Treatments (47 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Cancer therapeutics and mechanisms (12 papers). Suzanne Shusterman collaborates with scholars based in United States, Canada and Switzerland. Suzanne Shusterman's co-authors include John M. Maris, Lisa Diller, Wendy B. London, Anna T. Meadows, Steven G. DuBois, Julia Glade Bender, Paul M. Sondel, Peter C. Adamson, Susan M. Blaney and Ashish M. Ingle and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Suzanne Shusterman

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Shusterman United States 23 738 645 642 384 343 63 1.7k
Adela Cañete Spain 26 1.4k 1.9× 940 1.5× 535 0.8× 622 1.6× 167 0.5× 144 2.4k
Max M. van Noesel Netherlands 27 1.1k 1.5× 831 1.3× 541 0.8× 565 1.5× 169 0.5× 83 2.3k
Ashish M. Ingle United States 24 815 1.1× 1.2k 1.9× 788 1.2× 348 0.9× 151 0.4× 36 2.5k
Godelieve A.M. Tytgat Netherlands 26 1.3k 1.8× 876 1.4× 429 0.7× 908 2.4× 131 0.4× 110 2.1k
Stephen S. Roberts United States 20 743 1.0× 508 0.8× 382 0.6× 303 0.8× 195 0.6× 73 1.3k
Pooja Hingorani United States 24 285 0.4× 577 0.9× 725 1.1× 298 0.8× 307 0.9× 72 1.8k
Howard M. Katzenstein United States 36 1.4k 1.8× 1.2k 1.9× 978 1.5× 707 1.8× 132 0.4× 111 3.5k
Allen Buxton United States 21 1.8k 2.4× 1.0k 1.6× 977 1.5× 528 1.4× 381 1.1× 49 3.1k
Isabelle Aerts France 28 564 0.8× 839 1.3× 761 1.2× 306 0.8× 113 0.3× 125 2.6k
Lynley V. Marshall United Kingdom 17 309 0.4× 459 0.7× 439 0.7× 207 0.5× 144 0.4× 62 1.2k

Countries citing papers authored by Suzanne Shusterman

Since Specialization
Citations

This map shows the geographic impact of Suzanne Shusterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Shusterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Shusterman more than expected).

Fields of papers citing papers by Suzanne Shusterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Shusterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Shusterman. The network helps show where Suzanne Shusterman may publish in the future.

Co-authorship network of co-authors of Suzanne Shusterman

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Shusterman. A scholar is included among the top collaborators of Suzanne Shusterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Shusterman. Suzanne Shusterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shulman, David S., Kieuhoa T. Vo, Frank M. Balis, et al.. (2025). A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors. Cancer Medicine. 14(23). e71417–e71417.
2.
3.
Parra‐Herran, Carlos, Bradley J. Quade, Suzanne Shusterman, et al.. (2023). STK11 Adnexal Tumor in an Adolescent Female: Diagnostic Pitfalls of a Recently Described Entity. Pediatric and Developmental Pathology. 26(5). 486–493. 4 indexed citations
4.
Shulman, David S., Stacey L. Edwards, Catherine Clinton, et al.. (2021). Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Cancer Medicine. 10(7). 2310–2318. 6 indexed citations
5.
Liu, Kevin X., Natalie B. Collins, Katie A. Greenzang, et al.. (2020). The use of interval‐compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatric Blood & Cancer. 67(10). e28559–e28559. 12 indexed citations
6.
Mack, Jennifer W., Hajime Uno, Clare J. Twist, et al.. (2020). Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer. Journal of Pain and Symptom Management. 60(4). 782–789. 35 indexed citations
7.
Mack, Jennifer W., Angel M. Cronin, Hajime Uno, et al.. (2019). Unrealistic parental expectations for cure in poor‐prognosis childhood cancer. Cancer. 126(2). 416–424. 38 indexed citations
8.
Hughes, Amy, Robert C. Shamberger, Suzanne Shusterman, et al.. (2019). A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma. Thyroid. 29(11). 1704–1707. 24 indexed citations
9.
10.
Li, Richard, Alexei L. Polishchuk, Steven G. DuBois, et al.. (2016). Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation. International Journal of Radiation Oncology*Biology*Physics. 97(2). 270–277. 23 indexed citations
11.
Harris, Marian H., Steven G. DuBois, Julia Glade Bender, et al.. (2016). Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors. JAMA Oncology. 2(5). 608–608. 119 indexed citations
12.
Krishnadas, Deepa Kolaseri, Suzanne Shusterman, Fanqi Bai, et al.. (2015). A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma. Cancer Immunology Immunotherapy. 64(10). 1251–1260. 133 indexed citations
13.
Grupp, Stephan A., Eline T. Luning Prak, Jean Boyer, et al.. (2012). Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma. Clinical Cancer Research. 18(24). 6732–6741. 31 indexed citations
14.
Minturn, Jane E., Audrey E. Evans, Judith G. Villablanca, et al.. (2011). Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemotherapy and Pharmacology. 68(4). 1057–1065. 67 indexed citations
15.
Shusterman, Suzanne, Frederick D. Grant, Royal T. Davis, et al.. (2011). Iodine-131–labeled Meta-Iodobenzylguanidine Therapy of Children with Neuroblastoma: Program Planning and Initial Experience. Seminars in Nuclear Medicine. 41(5). 354–363. 21 indexed citations
16.
DuBois, Steven G., Suzanne Shusterman, Joel M. Reid, et al.. (2011). Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children’s Oncology Group study. Cancer Chemotherapy and Pharmacology. 69(4). 1021–1027. 32 indexed citations
17.
Matthay, Katherine K., Alekist Quach, John P. Huberty, et al.. (2009). Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study. Journal of Clinical Oncology. 27(7). 1020–1025. 79 indexed citations
18.
Fang, Junjie, Suzanne Shusterman, Ronald D. Barr, et al.. (2001). Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model.. PubMed. 7(4). 1026–32. 5 indexed citations
19.
Weiss, Matthew J., Chun Guo, Suzanne Shusterman, et al.. (2000). Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13. Medical and Pediatric Oncology. 35(6). 526–530. 21 indexed citations
20.
Shusterman, Suzanne & Anna T. Meadows. (2000). Long term survivors of childhood leukemia. Current Opinion in Hematology. 7(4). 217–222. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adela Cañete Breakdown of academic impact, for papers by Max M. van Noesel Breakdown of academic impact, for papers by Ashish M. Ingle Breakdown of academic impact, for papers by Godelieve A.M. Tytgat Breakdown of academic impact, for papers by Stephen S. Roberts Breakdown of academic impact, for papers by Pooja Hingorani Breakdown of academic impact, for papers by Howard M. Katzenstein Breakdown of academic impact, for papers by Allen Buxton Breakdown of academic impact, for papers by Isabelle Aerts Breakdown of academic impact, for papers by Lynley V. Marshall
Rankless by CCL
2026